Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited

No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported 14.28 INR per share, beating the 18.70 INR estimate by −23.64%. Revenue for the same period reached ‪39.01 B‬ INR, despite the estimate of ‪38.33 B‬ INR.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise